Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!

What fueled the previous growth in the hydronephrosis market?

In recent times, there has been a swift expansion in the size of the hydronephrosis market. It is anticipated to increase from a value of $3.06 billion in 2024 to $3.38 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. The impressive growth witnessed in the previous period can be credited to factors such as an increased occurrence of kidney stones, a heightened number of urinary tract infections, a growing elderly population, enhanced awareness and early detection, as well as increased spending in the healthcare sector.

What will be the hydronephrosis market size in the future?

In the coming years, the hydronephrosis market is anticipated to witness a substantial growth, reaching a market size of $4.99 billion in 2029, with a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this growth during the forecasted period include an increased number of chronic kidney disease cases, higher adoption of less intrusive surgical procedures, rising emphasis on early diagnosis, healthcare infrastructure expansion, and the introduction of novel treatment methods. Also influencing this market trend are the growth of personalized medicine, expanding use of artificial intelligence in diagnosis procedures, progress in non-invasive treatment techniques, the surge in patient-focused healthcare strategies, and the adoption of telemedicine within nephrology.

Get your hydronephrosis market report here!

https://www.thebusinessresearchcompany.com/report/hydronephrosis-global-market-report

What main drivers are fueling expansion in the hydronephrosis market?

The escalating occurrences of kidney diseases are anticipated to spur the expansion of the hydronephrosis market in the coming times. Kidney affliction, or renal disease or nephropathy, constitutes a series of conditions bringing about the deterioration of the kidneys, hence, diminishing their capability to effectively purify blood. The growth in kidney disease cases can be attributed to various factors, such as increasing instances of diabetes and hypertension, obesity, an aging population, along with genetic and ethnic influences. Hydronephrosis is managed by dealing with the root cause of the urinary blockage which may necessitate the use of drugs, surgical procedures or other strategies to restore normal urine passage. For instance, a report by Kidney Research UK released in June 2023 explicates that at present, around 7.2 million UK residents are struggling with chronic kidney disease, accounting for over 10% of the populace. Out of these, 3.25 million are dealing with the disease’s advanced stages, while a supplementary 3.9 million are grappling with the initial stages. The figures of people suffering from chronic kidney disease is expected to rise to 7.61 million by 2033. Thus, the uprising occurrences of kidney diseases are promoting the growth of the hydronephrosis market.

What key areas define the segmentation of the global hydronephrosis market?

The hydronephrosis market covered in this report is segmented –

1) By Type: Unilateral Hydronephrosis, Bilateral Hydronephrosis

2) By Indication: Intrinsic, Extrinsic

3) By Diagnosis: Laboratory Test, Imaging

4) By Treatment: Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Other Treatments

Subsegments:

1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis, Acquired Unilateral Hydronephrosis, Obstructive Unilateral Hydronephrosis, Non-Obstructive Unilateral Hydronephrosis

2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis, Acquired Bilateral Hydronephrosis, Obstructive Bilateral Hydronephrosis, Non-Obstructive Bilateral Hydronephrosis

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20563&type=smp

Who are the dominant players expanding their reach in the hydronephrosis market?

Major companies operating in the hydronephrosis market are AbbVie Inc., Boston Scientific Corporation, Novartis AG, 3M Company, F. Hoffmann-La Roche Ltd, Medtronic PLC, Amgen Inc., Stryker Corporation, Thermo Fisher Scientific Inc., B. Braun Group, Terumo Interventional Systems, Sigma-Aldrich Co, Coloplast A/S, Cook Medical, KARL STORZ SE & Co. KG, Spire Healthcare Group plc, Promega Corporation, NantHealth Inc., UroGen Pharma Ltd., Natus Medical Incorporated, Renal Associates P.A., Urologix Inc., Savant Medical Group

How are evolving market trends shaping hydronephrosis Strategies?

Leading businesses within the hydronephrosis industry are seeking to improve patient care through the evolution of inventive products like drainage catheters. These catheters, used to extract fluids such as urine or blood from the body, offer efficient and minimally invasive solutions for kidney urine drainage and prevention of fluid build-up. For example, in October 2024, Argon Medical Devices Inc., an American manufacturer of specialty medical products, initiated the release of the SKATER mini-loop drainage catheter. This medical tool designed for non-invasive drainage of unwanted bodily fluid collections enters the body through the skin under imaging guidance. Equipped with a loop that’s 40% less in size, it guarantees safe positioning and effective drainage from smaller cavities. This catheter is recognized for its sturdiness, resilience to kinking, and alcohol compatibility, boosting its utility in interventional procedures. By enlarging Argon’s drainage products, the SKATER Mini-Loop aims to boost patient results and simplify the drainage process for health care professionals.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20563

Which regions are emerging as leaders in the hydronephrosis market?

North America was the largest region in the hydronephrosis market in 2024. The regions covered in the hydronephrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Diabetic Kidney Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Artificial Kidney Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: